Gastric juice for the diagnosis of H pylori infection in patients on proton pump inhibitors

World Journal of Gastroenterology

Volumn 14, Issue 10, 2008, Pages 1539-1543

  Yakoob, Javed ^a   Rasool, Shahid ^a   Abbas, Zaigham ^a   Jafri, Wasim ^a   Abid, Shahab ^a   Islam, Muhammad ^a   Ahmad, Zubair ^a  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

Author keywords

Gastric juice; H pylori; Histology; Polymerase chain reaction; Proton pump inhibitor

Indexed keywords

HELICOBACTER PYLORI UREASE C; OMEPRAZOLE; PROTON PUMP INHIBITOR; UNCLASSIFIED DRUG; UREASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DUODENUM ULCER; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; POLYMERASE CHAIN REACTION; PREDICTION; SENSITIVITY AND SPECIFICITY; STOMACH BIOPSY; STOMACH CARCINOMA; STOMACH JUICE; STOMACH ULCER;

EID: 41549153773     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.1539     Document Type: Article

References (27)

1. Blaser MJ. Ecology of Helicobacter pylori in the human stomach. J Clin Invest 1997; 100: 759-762
2. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, Stemmermann GN, Nomura A. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55: 2111-2115
3. Nizami SQ, Bhutta ZA, Weaver L, Preston T. Helicobacter pylon colonization in infants in a peri-urban community in Karachi, Pakistan. J Pediatr Gastroenterol Nutr 2005; 41: 191-194
4. Abid S, Hussain T, Rabbani F, Ahmed A. Seroprevalence and risk factors for H pylori. A population-based Study. Helicobacter 2003; 8: A395
5. Sturm AW, van der Pol R, Smits AJ, van Hellemondt FM, Mouton SW, Jamil B, Minai AM, Sampers GH. Over-the-counter availability of antimicrobial agents, self-medication and patterns of resistance in Karachi, Pakistan. J Antimicrob Chemother 1997; 39: 543-547
6. Malfertheiner P, Megraud F, O'Morain C, Hungin AP, Jones R, Axon A, Graham DY, Tytgat G. Current concepts in the management of Helicobacter pylori infection-the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002; 16: 167-180
7. Dickey W, Kenny BD, McConnell JB. Effect of proton pump inhibitors on the detection of Helicobacter pylori in gastric biopsies. Aliment Pharmacol Ther 1996; 10: 289-293
8. Yakoob J, Jafri W, Abbas Z, Abid S, Islam M, Ahmed Z. The diagnostic yield of various tests for Helicobacter pylori infection in patients on acid-reducing drugs. Dig Dis Sci 2008; 53: 95-100
9. Yakoob J, Jafri W, Abid S, Jafri N, Abbas Z, Hamid S, Islam M, Anis K, Shah HA, Shaikh H. Role of rapid urease test and histopathology in the diagnosis of Helicobacter pylori infection in a developing country. BMC Gastroenterol 2005; 5: 38
10. Datta S, Chattopadhyay S, Chowdhury A, Santra A, Saha DR, Ramamurthy T, Bhattacharya SK, Berg DE, Nair GB, Mukhopadhyay AK. Diagnosis and genotyping of Helicobacter pylori by polymerase chain reaction of bacterial DNA from gastric juice. J Gastroenterol Hepatol 2005; 20: 1253-1259
11. Fritz SB, Ulf Westblom T. PCR for the detection of H pylori in gastric juice aspirates and environmental water samples. In: H pylori Protocols. Methods in Molecular Medicine. Clayton CL, Mobley HLT. New Jersey: Humana press, 1997: 37-40
12. Doran GH, Dickel DN, Ballinger WE Jr, Agee OF, Laipis PJ, Hauswirth WW. Anatomical, cellular and molecular analysis of 8,000-yr-old human brain tissue from the Windover archaeological site. Nature 1986; 323: 803-806
13. Price AB. The Sydney System: histological division. J Gastroenterol Hepatol 1991; 6: 209-222
14. Labigne A, Cussac V, Courcoux P. Shuttle cloning and nucleotide sequences of Helicobacter pylori genes responsible for urease activity. J Bacteriol 1991; 173: 1920-1931
15. Perez-Perez GI, Olivares AZ, Cover TL, Blaser MJ. Characteristics of Helicobacter pylori variants selected for urease deficiency. Infect Immun 1992; 60: 3658-3663
16. Segal ED, Shon J, Tompkins LS. Characterization of Helicobacter pylori urease mutants. Infect Immun 1992; 60: 1883-1889
17. Stolte M, Bethke B. Elimination of Helicobacter pylori under treatment with omeprazole. Z Gastroenterol 1990; 28: 271-274
18. Bugnoli M, Bayeli P, Rappuoli R, Pennatini C, Figura N, Crabtree JE. Inhibition of Helicobacter pylori urease by omeprazole. Eur J Gastroenterol Hepatol 1993; 5: 683-685
19. Clyne M, Labigne A, Drumm B. Helicobacter pylori requires an acidic environment to survive in the presence of urea. Infect Immun 1995; 63: 1669-1673
20. Nakshabendi IM, Zhang QB, Mokhashi M, Gemmell CG, Lee FD, Russell RI. Effect of omeprazole therapy on the survival of Helicobacter pylori, urease activity, and antral gastric histology in patients with duodenal ulcer. Helicobacter 1996; 1: 155-158
21. Yoshida H, Hirota K, Shiratori Y, Nihei T, Amano S, Yoshida A, Kawamata O, Omata M. Use of a gastric juice-based PCR assay to detect Helicobacter pylori infection in culture-negative patients. J Clin Microbiol 1998; 36: 317-320
22. Katelaris PH, Seow F, Lin BP, Napoli J, Ngu MC, Jones DB. Effect of age, Helicobacter pylori infection, and gastritis with atrophy on serum gastrin and gastric acid secretion in healthy men. Gut 1993; 34: 1032-1037
23. Craanen ME, Blok P, Dekker W, Ferwerda J, Tytgat GN. Subtypes of intestinal metaplasia and Helicobacter pylori. Gut 1992; 33: 597-600
24. Graham DY, Genta R, Evans DG, Reddy R, Clarridge JE, Olson CA, Edmonds AL, Siepman N. Helicobacter pylori does not migrate from the antrum to the corpus in response to omeprazole. Am J Gastroenterol 1996; 91: 2120-2124
25. Verdu EF, Armstrong D, Idstrom JP, Labenz J, Stolte M, Dorta G, Borsch G, Blum AL. Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole. Gut 1995; 37: 743-748
26. Suzuki M, Suzuki H, Kitahora T, Miyazawa M, Nagahashi S, Suzuki K, Ishii H. Proton pump inhibitor modifies inflammatory reaction in human gastric mucosa infected by Helicobacter pylori. Aliment Pharmacol Ther 2002; 16 Suppl 2: 229-234
27. Lam SK, Talley NJ. Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection. J Gastroenterol Hepatol 1998; 13: 1-22